eConsent in Clinical Trials Market (By Type: On-premises, Cloud-based, Hybrid Deployment; By Application: Hospitals, CROs, Pharma and Biotech Organizations, and Others; By Region: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) Industry Size, Share, Growth, Trends 2025 to 2034
The global eConsent in clinical trials market size was evaluated at USD 311 million in 2024 and is expected to grow around USD 1,194.04 million by 2034, registering a CAGR of 14.4% from 2025 to 2034.
| Reports Attributes | Statistics |
| Market Size in 2024 | USD 311 Million |
| Market Size in 2025 | USD 355.78 Million |
| Market Size in 2031 | USD 797.52 Million |
| Market Size by 2034 | USD 1,194.04 Million |
| CAGR 2025 to 2034 | 14.4% |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Regions | Shares (%) |
| North America | 40% |
| Asia Pacific | 23% |
| Europe | 25% |
| LAMEA | 12% |
| Segments | Shares (%) |
| Interactive eConsent | 65% |
| Static eConsent | 35% |
| Segments | Shares (%) |
| Pharmaceutical & Biotech Companies | 45% |
| CROs | 25% |
| Hospitals & Research Centers | 20% |
| Others | 10% |
Published by Ajit Bansod
